29 Jun 2015 --- A new compound of animal origin, isolated from the porcine brain and completely developed by Bioiberica investigators, has achieved positive results in slowing down the progression of Alzheimer's in seven studies using animals. This compound is PRJ212, which has a new mechanism of action based on neuroprotection and which could prevent memory loss in patients at the mild stage.
